Neuronal responses to cannabinoid receptor ligands in the solitary tract nucleus

By Himmi T.   Perrin J.   El Ouazzani T.   Orsini J.-C.  

European Journal of Pharmacology, Vol. 359, Iss. 1, 1998-10 ,pp. : 49-54

Elsevier

Access to resources Recommend Favorite

Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 35, 2014-11 ,pp. : 4046-4058

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot topic: Endocannabinoid Receptor System (Guest Editor: Robyn A. Puffenbarger)]

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-12 ,pp. : 402-402

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of the cannabinoid CB 2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB 2 receptor absence in the rat central nervous system

By Griffin G.   Wray E.J.   Tao Q.   McAllister S.D.   Rorrer W.K.   Aung M.   Martin B.R.   Abood M.E.  

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 117-125

Elsevier

Access to resources Recommend Favorite

The Endocannabinoid System and Huntington's Disease

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 335-347

Bentham Science Publishers

Access to resources Recommend Favorite